Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$7.65 -0.13 (-1.67%)
At close: Oct 23, 2026 · 4:00 PM EDT

Biocryst Pharmaceuticals (BCRX) Sale and Maturity of Investments (2010 - 2026)

Updated

Analysis

Biocryst Pharmaceuticals (BCRX) Sale and Maturity of Investments (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Biocryst Pharmaceuticals 1.95 Bn 874.18 Mn 214.41 Mn 25.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.70 Mn
Mar 31, 2026 221.24 Mn
Dec 31, 2025 49.00 Mn
Sep 30, 2025 73.00 Mn
Jun 30, 2025 58.65 Mn
Mar 31, 2025 76.00 Mn
Dec 31, 2024 58.00 Mn
Sep 30, 2024 35.48 Mn
Jun 30, 2024 110.00 Mn
Mar 31, 2024 117.00 Mn
Dec 31, 2023 129.07 Mn
Sep 30, 2023 148.00 Mn
Jun 30, 2023 66.33 Mn
Mar 31, 2023 41.69 Mn
Dec 31, 2022 77.74 Mn
Sep 30, 2022 35.66 Mn
Jun 30, 2022 4.00 Mn
Sep 30, 2021 8.11 Mn
Jun 30, 2021 5.32 Mn
Mar 31, 2021 14.77 Mn
API Access

Biocryst Pharmaceuticals Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=BCRX&period=max&api_key=YOUR_API_KEY